Deupirfenidone, a potential new treatment for idiopathic pulmonary fibrosis, is set to be tested in a phase 3 trial this year after a successful phase 2b trial and meeting with the FDA, according to a ...
The transition to S/4HANA represents a transformation for the entire company. The associated challenges can be effectively ...
A flue cap at the top of Peel Power Station was damaged amid Storm Éowyn in January 2025, which brought violent storm force ...
Researchers have uncovered the enzyme behind chromothripsis, a chaotic chromosome-shattering event seen in about one in four cancers. The enzyme, N4BP2, breaks apart DNA trapped in tiny cellular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results